Basic Information
Vast Therapeutics, a subsidiary of KNOW Bio and formerly known as Novoclem Therapeutics, is dedicated to developing BIOC51, an inhaled nitric oxide therapy, to treat cystic fibrosis patients battling chronic Pseudomonas aeruginosa infections.
Vast Therapeutics, Inc.
NorthCarolina,United States of America
less than 15 people
January 01, 2017
info@vasttherapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios